Cardio Diagnostics Holdings (CDIO) Operating Expenses (2021 - 2026)

Cardio Diagnostics Holdings has disclosed Operating Expenses across 6 years of filings, most recently posting $1.5 million for Q2 2026.

• In Q2 2026, Operating Expenses fell 10.83% year-over-year to $1.5 million; the TTM figure through Jun 2026 stood at $6.5 million (up 3.49% YoY), while the FY2025 annual figure was $6.5 million, down 22.64% from the prior year.
• Operating Expenses came in at $1.5 million for Q2 2026 at Cardio Diagnostics Holdings, down from $1.8 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $4.2 million in Q1 2024 to a low of $232555.0 in Q1 2022.
• Average Operating Expenses over 5 years is $1.7 million, with a median of $1.5 million recorded in 2023.
• Year-over-year, Operating Expenses soared 198127.71% in 2022 and sank 60.91% in 2025.
• Over 5 years, Operating Expenses stood at $2.4 million in 2022, then plunged by 34.96% to $1.5 million in 2023, then fell by 1.71% to $1.5 million in 2024, then slipped by 3.56% to $1.5 million in 2025, then advanced by 2.5% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $1.5 million in Q2 2026, $1.8 million in Q1 2026, and $1.5 million in Q4 2025.